The purposes of the Society are scientific, educational, literary, charitable, and no other.
This conference is being held in conjunction with the Massive Analysis And Quality Control Society (MAQC) annual meeting.
Since 2005, the FDA has led the MicroArray Quality Control (MAQC) consortium, which is a community wide effort to address reproducibility issues relating to the application of constantly evolving high‐throughput genomics technologies to either assess safety and efficacy of FDA regulated products and their safe and effective use in clinical applications. The MAQC consortium completed three projects between 2005 ‐2014 (namely MAQC I, II and III), resulting in ~30 publications. Its fourth project, also called SEquencing Quality Control Phase II (SEQC II) project will be completed in 2021. The MAQC Society is derived from the MAQC consortium.ABOUT MAQC